Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Vela Dx Launches RUO Kits for H7N9, MERS-CoV

Premium

Singapore's Vela Diagnostics this week announced the availability of PCR-based research use-only tests for the identification of genetic targets specific to a new strain of bird flu (H7N9), as well as a highly virulent strain of coronavirus known as Middle East respiratory syndrome coronavirus, or MERS-CoV.

With concerns about the potential of both pathogens to cause global outbreaks, Vela's assays are part of a broader program directed at investigating the assays' potential as surveillance tools for patients suspected of being infected with the viruses, Vela said.

The tests will run on Vela's Sentosa workflow, a fully automated molecular diagnostics platform featuring real-time PCR-based detection. The company said that the tests will provide results in as little as four hours.

Vela said that it developed the H7N9 bird flu test under a partnership with Singapore's PathGen Dx.

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.